andrei_r_-_shutterstock_1935537274_720

Byondis and Glycotope to collaborate on antibodies against novel GlycoTargets

July 27, 2021
Manufacturing and Production

Byondis and Glycotope have entered into a platform access agreement to discover and develop antibodies that target specific tumour-associated protein/carbohydrate …

BioNTech set to develop first mRNA malaria vaccine

July 27, 2021
Manufacturing and Production, Research and Development

Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …

Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds

July 27, 2021
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …

Purdue Pharma votes for bankruptcy plan to pay for its role in US opioid crisis

July 27, 2021
Manufacturing and Production

Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to …

US purchases further 200M Pfizer vaccines for children and possible boosters

July 26, 2021
Sales and Marketing

The Biden administration has purchased an additional 200 million Pfizer-BioNTech COVID-19 vaccines for children, as well as for potential booster …

15-minute Covid-19 immune status test launched in the UK and Ireland

July 26, 2021
Sales and Marketing

Luas Diagnostics has launched a 15-minute test to determine immunity to Covid-19 post infection or vaccination. The product, which is …

Moderna jab approved for children aged 12-17 in the EU

July 26, 2021
Sales and Marketing

The EU has approved the use of the Moderna COVID vaccine in children aged 12-17. Pfizer’s jab got the green …

mask-4898571_1280

Latest UK figures show COVID cases are falling

July 26, 2021
Sales and Marketing

The number of people testing positive with COVID-19 is falling in the UK. The UK recorded 29,173 new cases on …

FDA approves Beximco Pharma’s muscle relaxant drug Baclofen

July 26, 2021
Sales and Marketing

Beximco Pharma has received FDA approval for Baclofen (10 and 20 mg tablets). Baclofen is a muscle relaxant drug indicated …

New NICE guideline on C. difficile rejects metronidazole prescription

July 23, 2021
Medical Communications

NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …

pfizer_building_logo2_1

Eight-week vaccine gap with Pfizer is best for antibodies

July 23, 2021
Medical Communications

UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …

Expansion for first FDA-approved video game for ADHD treatment

July 23, 2021
Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …

Biogen pens open letter to Alzheimer’s community

July 23, 2021
Medical Communications

In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …

Parents warned as child respiratory illness on the rise this summer

July 23, 2021
Medical Communications

Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …

cdc-un8tv9pw2ik-unsplash_1

Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …

Bayer/MSD heart failure drug gains EC approval

July 22, 2021

The European Commission (EC) has approved MSD and Bayer’s Verquvo (vericiguat) for the treatment of symptomatic chronic heart failure in …

China rejects a second WHO probe into COVID outbreak origin

July 22, 2021
COVID-19, China

China has rejected WHO plans for a second investigation into the origin of the coronavirus pandemic, which includes the hypothesis …

roche__tree

Roche discussing potential Alzheimer’s treatment with FDA

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …

NICE approves treatment for rare bile duct cancer

July 22, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …

catalent

$100 million expansion planned for Catalent’s Italian vaccine plant

July 21, 2021
Manufacturing and Production, Research and Development

Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …

The Gateway to Local Adoption Series

Latest content